Biohaven Stock (NYSE: BHVN) stock price, news, charts, stock research, profile.
You can purchase shares of Biohaven (NYSE:BHVN) through any online brokerage.
Other companies in Biohaven’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
Biohaven has a consensus price target of $78.44.
The stock price for Biohaven (NYSE: BHVN) is $46.83 last updated November 21, 2024 at 7:10 AM EST.
There are no upcoming dividends for Biohaven.
Biohaven’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Biohaven.
Biohaven is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.